This is a mechanism module, not a specific disease; do NOT create a "Germinal Center Reaction" Disease entry. Unlike most modules in kb/modules/, the process modelled here is normal physiology rather than a lesion, so the description does not open by calling itself a pathophysiology module; it follows innate_antiviral_interferon_response and host_directed_antiviral_dependency in naming the pathway directly. Disorder entries reference individual nodes via conforms_to (e.g. "germinal_center_reaction#Germinal Center Reaction"). The module defines the expected pathophysiology structure; conforming nodes should carry the corresponding cell types, biological processes, and causal edges, specialized to their disease context and directed with modifiers. Disorder-specific substitutions: an antibody-deficiency conformer substitutes its own molecular lesion for the generic step and reads the chain in the DECREASED or ABSENT direction (CVID at class switch recombination, APDS at B-cell maturation, Kabuki syndrome at somatic hypermutation, Specific Antibody Deficiency at the switched memory compartment, autosomal agammaglobulinemia at the humoral-immunity consequence, where the reaction never starts because no naive B cell reaches the follicle, Hyper-IgM syndrome type 2 at the reaction node itself, both processes read ABSENT because biallelic AICDA loss abolishes class switch recombination and somatic hypermutation together while germinal centers persist and enlarge, and X-linked agammaglobulinemia at the humoral-immunity consequence, the same shape as autosomal agammaglobulinemia since BTK loss arrests B-cell development at the pre-B stage before any cell reaches the follicle); a germinal-center-derived lymphoma substitutes the transformed clone and reads it in the dysregulated direction (Follicular_Lymphoma at the reaction node and at Tfh help). Selective IgA deficiency was assessed as a candidate conformer (issue #11897) and excluded: its defect is isotype-restricted (normal IgG and IgM by the disease's own case definition, where every declared conformer fails the reaction broadly) and its immunoglobulin heavy-chain alpha loci are structurally intact, so there is no lesion in this chain for it to substitute; the exclusion rationale is recorded on the entry itself. Explicitly out of scope, each to be argued as its own module: immunosenescence (upstream and age-driven, and the natural home for the poor-vaccine-response line inflammaging currently carries only as a model limitation); iatrogenic B-cell depletion (rituximab, transplant immunosuppression); asplenia and polysaccharide non-response, which run through T-independent antigens this chain does not cover; and waning immunity, which is plasma-cell survival kinetics rather than response failure. Vaccine effectiveness is deliberately not modelled as a module: it is the outcome of an intervention, and its failure modes do not share a causal chain — this module is the conserved process underneath the largest of them, and vaccine non-response is one readout of it rather than its definition (issue #10924). Mouse knockout data are used for the AID requirement and are graded MODEL_ORGANISM; the human requirement rests on the HIGM2 patient series. Immunoglobulin isotypes, AID chemistry, and BCL2 translocation are described in prose only; modules bind GO, CL, and UBERON terms and do not use gene (HGNC) or chemical (CHEBI) term bindings.
Antigen Capture and Naive B Cell Activation
trigger
Antigen draining into a secondary lymphoid organ is filtered and retained rather than passively diffusing through it: subcapsular sinus macrophages and follicular dendritic cells display intact, unprocessed antigen to B cells following defined migration paths through the follicle. A naive B cell whose receptor binds that antigen is activated, internalizes and processes it, and presents peptide on MHC class II, becoming competent to solicit T cell help. This is the entry point of the reaction; conformers whose B cells never reach the follicle (developmental arrest in bone marrow B lymphopoiesis) fail here by never starting.
Downstream
-
Cognate T Follicular Helper Cell Help
Cognate T Follicular Helper Cell Help
amplifier
An antigen-engaged B cell forms a cognate synapse with a CD4+ T cell that has differentiated along the Bcl6-dependent T follicular helper (Tfh) program. Tfh cells are the specialized CD4+ subset licensed to deliver follicular help, and their help is required both to nucleate a germinal center and to sustain the affinity-based selection that runs inside it. This node is the amplifier: a numerically small T cell population converts a single antigen-binding event into a self-sustaining, iteratively selected B cell reaction. Conformers substitute the specific lesion in T-B collaboration (costimulation, cytokine, or transcriptional) or, in germinal-center-derived lymphoma, a Tfh-containing supportive microenvironment that props up the transformed clone.
Germinal Center Reaction
central effector
Helped B cells seed a germinal center, a transient compartment within the follicle in which clonal expansion, AID-dependent somatic hypermutation of the immunoglobulin variable region, and class switch recombination proceed under iterative affinity-based selection. Mutation diversifies the receptor repertoire, selection retains the clones whose receptors bind antigen best, and switching changes the effector class of the antibody without changing its specificity. This is the rate-limiting, disorder-agnostic step every conformer funnels through and the module's key conformance target. Loss of AID abolishes both switching and hypermutation while leaving the germinal center itself enlarged, which is the cleanest demonstration that this node is a distinct mechanistic step rather than a synonym for germinal center formation. That AID argument licenses bundling somatic hypermutation with class switch recombination specifically; affinity-based selection is Tfh-driven light-zone biology and is mechanistically separable from AID-dependent mutation (CD40L and ICOS defects impair selection without touching AID). It is bundled here anyway because one rate-limiting conformance target is worth more to conformers than atomicity would be.
Downstream
-
Affinity-Matured Class-Switched B Cell Output
Affinity-Matured Class-Switched B Cell Output
effector
Selected germinal center B cells exit as two durable populations: long-lived plasma cells that home to the bone marrow and secrete affinity-matured, class-switched antibody continuously, and memory B cells that persist without secreting and mount an accelerated response on re-encounter with antigen. These are functionally distinct outputs of the same reaction — one maintains a standing serum antibody titre, the other supplies recall capacity — and a conformer may lose either selectively, which is why the module keeps them in one node rather than collapsing them into the consequence below.
Downstream
-
Durable Protective Humoral Immunity
Durable Protective Humoral Immunity
consequence
The standing serum and mucosal antibody maintained by long-lived plasma cells, together with the recall capacity held by memory B cells, constitutes durable protection against reinfection. This is the clinical consequence of the chain and the level at which it is measured: antibody titre and immune memory are the correlates of protection by which vaccines are judged, so vaccine non-response is one readout of this node rather than a mechanism of its own. Conformers read this node in the direction their disease takes it — absent in antibody deficiency, misdirected in autoantibody-mediated disease.